Navigating Early-Stage Innovation: Strategies from Genesis to Exit 00:10:00
Elizabeth joined LifeSci Capital in 2021 from SVB Leerink where she worked on the Equity Capital Markets and Corporate Access teams. Elizabeth partners with healthcare and life science companies to position them for success in the public markets and specializes in investor marketing strategy. Prior to SVB Leerink, Elizabeth served as a Vice President, Institutional Equity Sales at Sterne Agee CRT.
